Meiragtx Holdings Plc Revenue per Employee (MGTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Meiragtx Holdings Plc  (NASDAQ: MGTX)
 

Meiragtx Holdings Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 8608.59% in the second quarter 2026, year on year to cumulative value of $398 million, Meiragtx Holdings Plc's revenue per employee grew on a trailing twelve months basis to $ 986,355, this marks a new company high.
Within the Healthcare sector Employees of 395 other companies have achieved higher revenue per employee. While Meiragtx Holdings Plc's total ranking has deteriorated compared to the previous quarter from 2363 to 3022. Meiragtx Holdings Plc has 403 employees.


What is Sales per Employee Ratio?







MGTX Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 8608.59 % -84.79 % 252.33 % -96.24 % 1208.87 %
Sales per Employee (TTM) $ 986,355 197,911 201,963 68,032 94,087
MGTX's Total Ranking # 3022 # 2363 # 1112 # 1919 # 1914
Seq. Revenue Change 109604.44 % -99.61 % 18281.46 % -88.89 % 91.64 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 47
Healthcare Sector # 396
Overall Market # 3022

Revenue per Employee Statistics
High Average Low
$ 986,355 $ 99,385 $ 15,886
(Jun 30 2026)   (Jun 30 2023)



Financial Statements
Meiragtx Holdings Plc's Revenue MRQ $ 321 Millions Visit MGTX's Income Statement
Meiragtx Holdings Plc's Revenues TTM $ 398 Millions Visit MGTX's aggregate revenue growth
What are MGTX's Sales? Visit MGTX's Sales by Segment




Other Ratios
Meiragtx Holdings Plc's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MGTX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MGTX's Competitors
Revenue per Employee for MGTX's Suppliers
Revenue per Employee for MGTX's Customers

You may also want to know
MGTX's Sales Growth Rates MGTX's Pe Price to earnings ratio MGTX's Receivables Turnover Ratio MGTX's Stock Quote
MGTX's Net Income Growth Rates MGTX's Ps Price to Sales ratio MGTX's Sales per Employee MGTX's Asset Turnover Ratio
MGTX's Net Margin MGTX's Pb Price to Book ratio MGTX's Financial Strength Ratios MGTX's Dividend Payout Ratio
Date modified: 2026-09-12T06:23:21+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million 2 
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Bristol myers Squibb Company  1,513,415.38 $ 49,186.000  Million 32,500 
Krystal Biotech Inc   1,493,166.10 $ 440.484  Million 295 
Acadia Pharmaceuticals Inc   1,426,870.93 $ 1,138.643  Million 798 
Madrigal Pharmaceuticals Inc   1,403,213.11 $ 1,283.940  Million 915 
Indivior Pharmaceuticals Inc   1,333,000.00 $ 1,333.000  Million 1,000 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Supernus Pharmaceuticals inc   1,273,677.91 $ 830.438  Million 652 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Abbvie Inc   1,129,578.95 $ 64,386.000  Million 57,000 
Akebia Therapeutics Inc   1,129,175.26 $ 219.060  Million 194 
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.